Log in

OTCMKTS:TLOG - Tetralogic Pharmaceuticals Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
Now: $0.05
50-Day Range
MA: $0.04
52-Week Range
Now: $0.05
Volume1,601 shs
Average Volume6,737 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:TLOG
Previous SymbolNASDAQ:TLOG



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive TLOG News and Ratings via Email

Sign-up to receive the latest news and ratings for TLOG and its competitors with MarketBeat's FREE daily newsletter.

Tetralogic Pharmaceuticals (OTCMKTS:TLOG) Frequently Asked Questions

What is Tetralogic Pharmaceuticals' stock symbol?

Tetralogic Pharmaceuticals trades on the OTCMKTS under the ticker symbol "TLOG."

Has Tetralogic Pharmaceuticals been receiving favorable news coverage?

Headlines about TLOG stock have been trending very positive recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tetralogic Pharmaceuticals earned a media sentiment score of 3.1 on InfoTrie's scale. They also gave news articles about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Tetralogic Pharmaceuticals.

Who are some of Tetralogic Pharmaceuticals' key competitors?

What other stocks do shareholders of Tetralogic Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tetralogic Pharmaceuticals investors own include NovaBay Pharmaceuticals (NBY), Celgene (CELG), Trevena (TRVN), Vaxart (VXRT), Arrowhead Pharmaceuticals (ARWR), Sangamo Therapeutics (SGMO), Achieve Life Sciences (ACHV), Gilead Sciences (GILD), GoPro (GPRO) and OHR Pharmaceutical (OHRP).

Who are Tetralogic Pharmaceuticals' key executives?

Tetralogic Pharmaceuticals' management team includes the folowing people:
  • Dr. Yigong Shi, Co-Founder
  • Sarah E. Frew, Director of Bus. & Commercial Devel.

How do I buy shares of Tetralogic Pharmaceuticals?

Shares of TLOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tetralogic Pharmaceuticals' stock price today?

One share of TLOG stock can currently be purchased for approximately $0.05.

What is Tetralogic Pharmaceuticals' official website?

The official website for Tetralogic Pharmaceuticals is http://www.tetralogicpharma.com/.

How can I contact Tetralogic Pharmaceuticals?

Tetralogic Pharmaceuticals' mailing address is 343 PHOENIXVILLE PIKE, MALVERN PA, 19355. The biopharmaceutical company can be reached via phone at 610-889-9900 or via email at [email protected]

MarketBeat Community Rating for Tetralogic Pharmaceuticals (OTCMKTS TLOG)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  199
MarketBeat's community ratings are surveys of what our community members think about Tetralogic Pharmaceuticals and other stocks. Vote "Outperform" if you believe TLOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TLOG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel